Ryoji Miyahara

Early Changes in Alpha-Fetoprotein Are a Useful Predictor of Efficacy of Atezolizumab plus Bevacizumab Treatment in Patients with Advanced Hepatocellular Carcinoma

Teiji Kuzuya, Naoto Kawabe, Senju Hashimoto et al. · Oncology · 2021 · 43 citations

Medicine, Oncology, Pharmacotherapy +13

Changes in intestinal bacteria and imbalances of metabolites induced in the intestines of pancreatic ductal adenocarcinoma patients in a Japanese population: a preliminary result

Senju Hashimoto, Takumi Tochio, Kohei Funasaka et al. · Scandinavian Journal of Gastroenterology · 2022 · 33 citations

Life Sciences, Microbiology, Oncology +15

Subjective Symptoms in Patients with Eosinophilic Esophagitis Are Related to Esophageal Wall Thickness and Esophageal Body Pressure

Koichi Muroi, Naomi Kakushima, Kazuhiro Furukawa et al. · Digestive Diseases and Sciences · 2020 · 22 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +9

Clinical Outcomes With Lenvatinib in Patients Previously Treated With Atezolizumab/Bevacizumab for Advanced Hepatocellular Carcinoma

Hisanori Muto, Teiji Kuzuya, Naoto Kawabe et al. · Anticancer Research · 2023 · 20 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +15

Prevalence of Pancreatic Cystic Lesions Including Intraductal Papillary Mucinous Neoplasms in Patients With End-Stage Renal Disease on Hemodialysis

Takuya Ishikawa, Kinichi Takeda, Masatsugu Itoh et al. · Pancreas · 2009 · 19 citations

Medicine, Oncology, Pathology +16